Discontinued — last reported Q1 '24
Critical Care — Net Sales
Edwards Lifesciences Critical Care — Net Sales increased by 0.3% to $251.30M in Q1 2024 compared to the prior quarter. Year-over-year, this metric grew by 13.2%, from $221.90M to $251.30M. Over 2 years (FY 2021 to FY 2023), Critical Care — Net Sales shows an upward trend with a 5.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing adoption of the company's monitoring technologies in clinical settings, while a decrease may signal market saturation, increased competition, or reduced hospital capital expenditure.
Detailed definition
This metric represents the total revenue generated from the sale of advanced hemodynamic monitoring systems and related...
Peer comparison
Comparable to revenue segments for medical technology peers focused on patient monitoring, diagnostic equipment, or acute care hardware.
ew_segment_critical_care_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $215.00M | $212.70M | $211.60M | $212.10M | $210.60M | $207.30M | $225.00M | $221.90M | $234.70M | $221.00M | $250.50M | $251.30M |
| QoQ Change | — | -1.1% | -0.5% | +0.2% | -0.7% | -1.6% | +8.5% | -1.4% | +5.8% | -5.8% | +13.3% | +0.3% |
| YoY Change | — | — | — | — | -2.0% | -2.5% | +6.3% | +4.6% | +11.4% | +6.6% | +11.3% | +13.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's critical care — net sales?
- Edwards Lifesciences (EW) reported critical care — net sales of $251.30M in Q1 2024.
- How has Edwards Lifesciences's critical care — net sales changed year-over-year?
- Edwards Lifesciences's critical care — net sales increased by 13.2% year-over-year, from $221.90M to $251.30M.
- What is the long-term trend for Edwards Lifesciences's critical care — net sales?
- Over 2 years (2021 to 2023), Edwards Lifesciences's critical care — net sales has grown at a 5.4% compound annual growth rate (CAGR), from $834.90M to $928.10M.
- What does critical care — net sales mean?
- The total revenue earned from the company's critical care medical device and monitoring product line.